Browse > Article
http://dx.doi.org/10.15616/BSL.2020.26.4.310

Ameliorative Potential of Rengyolone Against CCI-induced Neuropathic Pain in Rats  

Lee, Gil-Hyun (Department of Clinical Laboratory Science, Dong-Seo University)
Hyun, Kyung-Yae (Department of Clinical Laboratory Science, Dong-Eui University)
Publication Information
Biomedical Science Letters / v.26, no.4, 2020 , pp. 310-318 More about this Journal
Abstract
The sciatic nerve is the largest nerve among the peripheral nerves, and the damage to the sciatic nerve is caused by mechanical and physical pressure. This is an important disease that consumes a lot of time and money in the treatment process. Among them, research on relieving nerve pain caused by damage to the peripheral sciatic nerve has been made efforts to prevent and treat this disease through various methods such as drugs, natural products, electrical stimulation, exercise therapy, and massage. Existing treatments are not very effective in neurological pain, and countermeasures are needed. Forsythia Fructus, used in this study, has been used as a therapeutic agent for infectious diseases and a pain reliever for cancer from the past, and in past studies, it has been known to properly control the inflammatory response. In this study, rengyolone, a physiologically active substance of Forsythiae Fructus, was administered to rats that caused chronic left nerve pain to verify the pain relief effect. As a result of the experiment, it was found that mechanical pain and cold stimulation pain were significantly reduced in the rengyolone-treated group compared to the non-administered group. In addition, it was found that nerve growth factor (NGF) mRNA expression was significantly reduced and Cyclin-dependent kinase 2 (Cdc2) expression was increased in the rengyolone administration group. This increase in NGF expression is thought to be related to rengyolone's anti-inflammatory regulatory mechanism. It is expected that the reduced NGF was directly involved in pain relief.
Keywords
Forsythiae Fructus; Rengyolone; NGF; Cdc2; Animal behavior;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Ahlgren SC, Wang JF, Levine JD. C-fiber mechanical stimulusresponse functions are different in inflammatory versus neuropathic hyperalgesia in the rat. Neuroscience. 1996. 76: 285-290.   DOI
2 Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology. 2006. 13: 1153-1169.   DOI
3 Bachewal P, Gundu C, Yerra VG, Kalvala AK, Areti A, Kumar A. Morin exerts neuroprotection via attenuation of ros induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Biofactors. 2018. 44: 109-122.   DOI
4 Bao J, Ding RB, Liang Y, Liu F, Wang K, Jia X, Zhang C, Chen M, Li P, Su H. Differences in chemical component and anticancer activity of green and ripe forsythiae fructus. The American Journal of Chinese Medicine. 2017. 45: 1513-1536.   DOI
5 Bao J, Liu F, Zhang C, Wang K, Jia X, Wang X, Chen M, Li P, Su H, Wang Y. Anti-melanoma activity of forsythiae fructus aqueous extract in mice involves regulation of glycerophospholipid metabolisms by uplc/q-tof ms-based metabolomics study. Scientific Reports. 2016. 6: 39415.   DOI
6 Baron R. Mechanisms of disease: Neuropathic pain-a clinical perspective. Nature Clinical Practice Neurology. 2006. 2: 95-106.   DOI
7 Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988. 33: 87-107.   DOI
8 Bennett GJ. An animal model of neuropathic pain: A review. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. 1993. 16: 1040-1048.
9 Bonin RP, Bories C, De Koninck Y. A simplified up-down method (sudo) for measuring mechanical nociception in rodents using von frey filaments. Molecular Pain. 2014. 10: 1744-8069.
10 Decosterd I, Woolf CJ. Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain. 2000. 87: 149-158.   DOI
11 Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact c-fiber nociceptors. Journal of Neuroscience. 2006. 26: 1281-1292.   DOI
12 Dong Z, Lu X, Tong X, Dong Y, Tang L, Liu M. Forsythiae fructus: A review on its phytochemistry, quality control, pharmacology and pharmacokinetics. Molecules. 2017. 22: 1466.   DOI
13 Fidanboylu M, Griffiths LA, Flatters SJL. Global inhibition of reactive oxygen species (ros) inhibits paclitaxel-induced painful peripheral neuropathy. PloS One. 2011. 6: e25212.   DOI
14 Fine EG, Decosterd I, Papaloïzos M, Zurn AD, Aebischer P. GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap. European Journal of Neuroscience. 2002. 15: 589-601.   DOI
15 Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 2005. 118: 289-305.   DOI
16 Hammarberg H, Piehl F, Cullheim S, Fjell J, Hokfelt T, Fried K. GDNF mRNA in schwann cells and DRG satellite cells after chronic sciatic nerve injury. Neuroreport. 1996. 7: 857-860.   DOI
17 Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, Shelton DL, Davies AM. Novel class of pain drugs based on antagonism of NGF. Trends in Pharmacological Sciences. 2006. 27: 85-91.   DOI
18 Herzberg U, Eliav E, Dorsey JM, Gracely RH, Kopin IJ. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport. 1997. 8: 1613-1618.   DOI
19 Hofmann HA, De Vry J, Siegling A, Spreyer P, Denzer D. Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain. European Journal of Pharmacology. 2003. 470: 17-25.   DOI
20 Kim JH, Kim DH, Baek SH, Lee HJ, Kim MR, Kwon HJ, Lee CH. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-κB and p38 map kinase activity in lps-stimulated raw 264.7 cells. Biochemical Pharmacology. 2006. 71: 1198-1205.   DOI
21 Kupers RC, Nuytten D, De Castro-Costa M, Gybels JM. A time course analysis of the changes in spontaneous and evoked behaviour in a rat model of neuropathic pain. Pain. 1992. 50: 101-111.   DOI
22 Lee BH, Won R, Baik EJ, Lee SH, Moon CH. An animal model of neuropathic pain employing injury to the sciatic nerve branches. Neuroreport. 2000. 11: 657-661.   DOI
23 Lee CH, Lee JE, Choi YJ, Lee EJ, Oh MS. Effects of the herbal medicine in animal models for treatment of sciatic nerve impairment: A review of animal study reports. Journal of Korean Medicine Rehabilitation. 2016. 26: 9-21.   DOI
24 Lee EB, Keum HJ. Pharmacological studies on forsythiae fructus. Korean Journal of Pharmacognosy. 1988. 19: 262-269.
25 Lee GH, Hyun KY, Kang YJ. Anti-inflammatory modulating effect of rengyolone in rat. Biomedical Science Letters. 2019. 25: 54-59.   DOI
26 Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 1997. 46: S38-S42.
27 Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE, Maier SF, Flotte TR. Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Molecular Pain. 2005. 1: 1744-8069.
28 Nishibe S, Okabe K, Tsukamoto H, Sakushima A, Hisada S, Baba H, Akisada T. Studies on the chinese crude drug" forsythiae fructus." Vi. The structure and antibacterial activity of suspensaside isolated from forsythia suspensa. Chemical and Pharmaceutical Bulletin. 1982. 30: 4548-4553.   DOI
29 Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. Proand anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Experimental Neurology. 2001. 169: 386-391.   DOI
30 Okuse K. Pain signalling pathways: From cytokines to ion channels. The International Journal of Biochemistry & Cell Biology. 2007. 39: 490-496.   DOI
31 Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. Journal of Pharmacology and Experimental Therapeutics. 2003. 306: 624-630.   DOI
32 Ramer MS, Bisby MA. Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: Distinct mechanisms revealed by anti-NGF treatment. European Journal of Neuroscience. 1999. 11: 837-846.   DOI
33 Schafers M, Sommer C. Anticytokine therapy in neuropathic pain management. Expert Review of Neurotherapeutics. 2007. 7: 1613-1627.   DOI
34 Sommer C, Schafers M. Mechanisms of neuropathic pain: The role of cytokines. Drug Discovery Today: Disease Mechanisms. 2004. 1: 441-448.   DOI
35 Treede RD. The international association for the study of pain definition of pain: As valid in 2018 as in 1979, but in need of regularly updated footnotes. Pain Report. 2018. 3.
36 Stagg NJ, Mata HP, Ibrahim MM, Henriksen EJ, Porreca F, Vanderah TW, Malan TP. Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain modelrole of endogenous opioids. Anesthesiology: The Journal of the American Society of Anesthesiologists. 2011. 114: 940-948.   DOI
37 Staud R, Bovee CE, Robinson ME, Price DD. Cutaneous c-fiber pain abnormalities of fibromyalgia patients are specifically related to temporal summation. Pain. 2008. 139: 315-323.   DOI
38 Staud R, Craggs JG, Robinson ME, Perlstein WM, Price DD. Brain activity related to temporal summation of c-fiber evoked pain. Pain. 2007. 129: 130-142.   DOI
39 Woolf C, Allchorne A, Safieh Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumour necrosis factor α. British Journal of Pharmacology. 1997. 121: 417-424.   DOI
40 Vissers K, Meert T. A behavioral and pharmacological validation of the acetone spray test in gerbils with a chronic constriction injury. Anesth Analg. Anesthesia & Analgesia. 2005. 101: 457-464.   DOI
41 Wu J, Zhao Z, Zhu X, Renn CL, Dorsey SG, Faden A. Cell cycle inhibition limits development and maintenance of neuropathic pain following spinal cord injury. Pain. 2016. 157: 488.   DOI
42 Yao D, Sessle BJ. Face sensorimotor cortex undergoes neuroplastic changes in a rat model of trigeminal neuropathic pain. Experimental Brain Research. 2018. 236: 1357-1368.   DOI
43 Youn SH, Kim SH, Park HS, Kim EY, Park HC, Park YG. The effect of mk-801 and naloxone in a sympathetically independent neuropathic pain rat model. Journal of Korean Neurosurgical Society. 2002. 32: 246-255.
44 Zhang Y, Miao H, Yan H, Sheng Y, Ji L. Hepatoprotective effect of forsythiae fructus water extract against carbon tetrachlorideinduced liver fibrosis in mice. Journal of Ethnopharmacology. 2018. 218: 27-34.   DOI
45 Zhuang J, Ma XR, Wang Xue. Thoughts on the treatment of cancer pain under the guidance of traditional chinese medicine. TMR Theory and Hypothesis. 2018. 1: 83-88.
46 Ziegler D, Hanefeld M, Ruhnau K, Mei H, Lobisch M, Schütte K, Gries F, Diabetologia ASGJ. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. 1995. Diabetologia. 38: 1425-1433.   DOI
47 Ziegler D, reviews. Painful diabetic neuropathy: Treatment and future aspects. 2008. 24: S52-S57.   DOI